Cargando…

New Prognostic Score (Essen Score) to Predict Postoperative Morbidity after Resection of Lung Metastases

SIMPLE SUMMARY: Pulmonary metastases from different primary tumors are a common issue in the everyday clinical praxis. The resection of lung metastases in patients selected by a multidisciplinary tumor board is a widely accepted surgical procedure that can prolong survival. The aim of the current re...

Descripción completa

Detalles Bibliográficos
Autores principales: Grapatsas, Konstantinos, Dörr, Fabian, Menghesha, Hruy, Schuler, Martin, Grünwald, Viktor, Bauer, Sebastian, Schmidt, Hartmut H. -J., Lang, Stephan, Kimmig, Rainer, Kasper, Stefan, Baldes, Natalie, Bölükbas, Servet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487257/
https://www.ncbi.nlm.nih.gov/pubmed/37686631
http://dx.doi.org/10.3390/cancers15174355
_version_ 1785103197361143808
author Grapatsas, Konstantinos
Dörr, Fabian
Menghesha, Hruy
Schuler, Martin
Grünwald, Viktor
Bauer, Sebastian
Schmidt, Hartmut H. -J.
Lang, Stephan
Kimmig, Rainer
Kasper, Stefan
Baldes, Natalie
Bölükbas, Servet
author_facet Grapatsas, Konstantinos
Dörr, Fabian
Menghesha, Hruy
Schuler, Martin
Grünwald, Viktor
Bauer, Sebastian
Schmidt, Hartmut H. -J.
Lang, Stephan
Kimmig, Rainer
Kasper, Stefan
Baldes, Natalie
Bölükbas, Servet
author_sort Grapatsas, Konstantinos
collection PubMed
description SIMPLE SUMMARY: Pulmonary metastases from different primary tumors are a common issue in the everyday clinical praxis. The resection of lung metastases in patients selected by a multidisciplinary tumor board is a widely accepted surgical procedure that can prolong survival. The aim of the current retrospective study is to investigate postoperative morbidity and mortality after pulmonary metastasectomy, identify risk factors and develop a prognostic score to identify high-risk patients. We identified 1284 patients with lung metastases that were resected with curative intent. For increased postoperative morbidity, we identified cardiovascular comorbidities, major lung resections, repeated pulmonary metastasectomy and open thoracotomy. Based on these factors, the Essen score was developed. We believe that the Essen score is a useful tool to predict postoperative morbidity in patients undergoing pulmonary metastasectomy with curative intent. ABSTRACT: Background: Pulmonary metastasectomy (PM) is a widely accepted surgical procedure. This study aims to investigate postoperative morbidity and mortality after PM and develop a score to predict high-risk patients. Methods: We retrospectively investigated all patients undergoing a PM in our institution from November 2012 to January 2023. Complications were defined as the diagnosis of any new disease after the PM up to 30 days after the operation. Results: 1284 patients were identified. At least one complication occurred in 145 patients (11.29%). Only one patient died during the hospital stay. Preoperative cardiovascular comorbidities (OR: 2.99, 95% CI: 1.412–3.744, p = 0.01), major lung resections (OR: 2.727, 95% CI: 1.678–4.431, p < 0.01), repeated pulmonary metastasectomy (OR: 1.759, 95% CI: 1.040–2.976, p = 0.03) and open thoracotomy (OR: 0.621, 95% CI: 0.415–0.930, p = 0.02) were identified as independent factors for postoperative complications. Based on the above independent factors for postoperative morbidity, the Essen score was developed (overall correct classification: 94.6%, ROC-Analysis: 0.828, 95% CI: 0.795–0.903). Conclusion: PM is a safe surgical procedure with acceptable morbidity and low mortality. The aim of the Essen score is to identify patients that are associated with risk for postoperative complications after PM.
format Online
Article
Text
id pubmed-10487257
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-104872572023-09-09 New Prognostic Score (Essen Score) to Predict Postoperative Morbidity after Resection of Lung Metastases Grapatsas, Konstantinos Dörr, Fabian Menghesha, Hruy Schuler, Martin Grünwald, Viktor Bauer, Sebastian Schmidt, Hartmut H. -J. Lang, Stephan Kimmig, Rainer Kasper, Stefan Baldes, Natalie Bölükbas, Servet Cancers (Basel) Article SIMPLE SUMMARY: Pulmonary metastases from different primary tumors are a common issue in the everyday clinical praxis. The resection of lung metastases in patients selected by a multidisciplinary tumor board is a widely accepted surgical procedure that can prolong survival. The aim of the current retrospective study is to investigate postoperative morbidity and mortality after pulmonary metastasectomy, identify risk factors and develop a prognostic score to identify high-risk patients. We identified 1284 patients with lung metastases that were resected with curative intent. For increased postoperative morbidity, we identified cardiovascular comorbidities, major lung resections, repeated pulmonary metastasectomy and open thoracotomy. Based on these factors, the Essen score was developed. We believe that the Essen score is a useful tool to predict postoperative morbidity in patients undergoing pulmonary metastasectomy with curative intent. ABSTRACT: Background: Pulmonary metastasectomy (PM) is a widely accepted surgical procedure. This study aims to investigate postoperative morbidity and mortality after PM and develop a score to predict high-risk patients. Methods: We retrospectively investigated all patients undergoing a PM in our institution from November 2012 to January 2023. Complications were defined as the diagnosis of any new disease after the PM up to 30 days after the operation. Results: 1284 patients were identified. At least one complication occurred in 145 patients (11.29%). Only one patient died during the hospital stay. Preoperative cardiovascular comorbidities (OR: 2.99, 95% CI: 1.412–3.744, p = 0.01), major lung resections (OR: 2.727, 95% CI: 1.678–4.431, p < 0.01), repeated pulmonary metastasectomy (OR: 1.759, 95% CI: 1.040–2.976, p = 0.03) and open thoracotomy (OR: 0.621, 95% CI: 0.415–0.930, p = 0.02) were identified as independent factors for postoperative complications. Based on the above independent factors for postoperative morbidity, the Essen score was developed (overall correct classification: 94.6%, ROC-Analysis: 0.828, 95% CI: 0.795–0.903). Conclusion: PM is a safe surgical procedure with acceptable morbidity and low mortality. The aim of the Essen score is to identify patients that are associated with risk for postoperative complications after PM. MDPI 2023-09-01 /pmc/articles/PMC10487257/ /pubmed/37686631 http://dx.doi.org/10.3390/cancers15174355 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Grapatsas, Konstantinos
Dörr, Fabian
Menghesha, Hruy
Schuler, Martin
Grünwald, Viktor
Bauer, Sebastian
Schmidt, Hartmut H. -J.
Lang, Stephan
Kimmig, Rainer
Kasper, Stefan
Baldes, Natalie
Bölükbas, Servet
New Prognostic Score (Essen Score) to Predict Postoperative Morbidity after Resection of Lung Metastases
title New Prognostic Score (Essen Score) to Predict Postoperative Morbidity after Resection of Lung Metastases
title_full New Prognostic Score (Essen Score) to Predict Postoperative Morbidity after Resection of Lung Metastases
title_fullStr New Prognostic Score (Essen Score) to Predict Postoperative Morbidity after Resection of Lung Metastases
title_full_unstemmed New Prognostic Score (Essen Score) to Predict Postoperative Morbidity after Resection of Lung Metastases
title_short New Prognostic Score (Essen Score) to Predict Postoperative Morbidity after Resection of Lung Metastases
title_sort new prognostic score (essen score) to predict postoperative morbidity after resection of lung metastases
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487257/
https://www.ncbi.nlm.nih.gov/pubmed/37686631
http://dx.doi.org/10.3390/cancers15174355
work_keys_str_mv AT grapatsaskonstantinos newprognosticscoreessenscoretopredictpostoperativemorbidityafterresectionoflungmetastases
AT dorrfabian newprognosticscoreessenscoretopredictpostoperativemorbidityafterresectionoflungmetastases
AT mengheshahruy newprognosticscoreessenscoretopredictpostoperativemorbidityafterresectionoflungmetastases
AT schulermartin newprognosticscoreessenscoretopredictpostoperativemorbidityafterresectionoflungmetastases
AT grunwaldviktor newprognosticscoreessenscoretopredictpostoperativemorbidityafterresectionoflungmetastases
AT bauersebastian newprognosticscoreessenscoretopredictpostoperativemorbidityafterresectionoflungmetastases
AT schmidthartmuthj newprognosticscoreessenscoretopredictpostoperativemorbidityafterresectionoflungmetastases
AT langstephan newprognosticscoreessenscoretopredictpostoperativemorbidityafterresectionoflungmetastases
AT kimmigrainer newprognosticscoreessenscoretopredictpostoperativemorbidityafterresectionoflungmetastases
AT kasperstefan newprognosticscoreessenscoretopredictpostoperativemorbidityafterresectionoflungmetastases
AT baldesnatalie newprognosticscoreessenscoretopredictpostoperativemorbidityafterresectionoflungmetastases
AT bolukbasservet newprognosticscoreessenscoretopredictpostoperativemorbidityafterresectionoflungmetastases